CANNAINVESTOR Magazine May / June 2017 - Page 53

Retail Investor's Perspective


The above referenced article also includes several links to studies that you can reference. Articles and reports such as this one appearing on are giving new hope to cancer patients and those searching for new treatments. There are many other studies and reports that you can research on your own and there can be little speculation as to why 8 of the CANNAINVESTOR TOP 13 long term stock picks (April USA issue) are from the sector. The research to date for dementia is also promising.

The research on Dementia and how cannabis can impede if not outright some of the underlying causes is impressive but just as preliminary. We also know that dementia is but one of many diseases that fall under the term “Degenerative neurological diseases”. Per that linked source: Such diseases cause abnormal changes to brain cells and usually have a clinical pattern that can be diagnosed. These diseases cause increasing disruption to neurological function as the disease progresses. Common examples of degenerative neurological diseases are Multiple Sclerosis, Huntington's disease, Parkinson's disease, Motor Neurone disease and Alzheimer's disease.

There has been sufficient clinical evidence to date to at least validate the use of medical marijuana in the treatment of Multiple Sclerosis; however, for the most part its success is deemed unknown at this time for many degenerative neurological diseases.